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4 Nitroxyl radicals have been widely used as spin probes for low frequency in vivo EPR experiments to estimate the biological redox status in living experimental animals (Berliner and Wan, 1989; Kuppusamy et al., 2002; Ilangovan et al., 2002; Yamada et al., 2002; Kasazaki et al., 2003) . When a nitroxyl spin probe is administered to a living animal, in vivo EPR signal intensities of the probe show characteristic signal intensity profiles as a function of time in the animal depending on the organ investigated. Generally, in vivo EPR signal decay rates are obtained based on a suitable region of its decay curve to estimate redox status in the animal (Yamada et al., 2002) .
Several nitroxyl radicals have been used in studies that exhibit EPR signal decay profiles depending on the spin probe used. The decay constant of a spin probe depends on the route of administration (i.e. intravenously, intraperitonealy, and etc.) and methodology of the analysis (i.e. 1-compartment model, 2-compartment model, and etc.) (Kocherginsky and Swartz, 1995) .
Moreover, species, strains and gender of experimental animal was also found to affect the EPR signal decay profiles (Kocherginsky and Swartz, 1995; Matsumoto et al., 2000) .
The following general observations can be summarized from earlier studies. The in vivo EPR signal decay rates of the spin probes are enhanced by reactive oxygen species (Utsumi et al, 1993; Sano et al., 1998; Phumala et al., 1999; Han et al., 2001) , such as hydroxyl radical and superoxide, which reduce nitroxyl radical in presence of H atom donor, such as NAD(P)H or GSH (Samuni et al., 1988; Krishna et al., 1992; Samuni et al., 2002; Takeshita et al., 2002) . In contrast, the decay rates are decreased due to re-oxidation of the hydroxylamine to the nitroxyl radical under the oxidative atmosphere such as exposure to hyperoxia or generation of hydrogen peroxide (Quaresima et al., 1993; Matsumoto et al., 2000) . Under reducing conditions as in hypoxic tumors, the decay rate constants of nitroxyl radicals were found to increase because re-JPET #66647 5 oxidation may be less efficient in such conditions (Minetti et al., 1991; Ilangovan et al., 2002; Kuppusamy et al., 2002) .
The signal decay rate also depends on several kinetic factors such as the distribution of the spin probe from the blood to the tissues and vice versa, urinary excretion through the kidney, fecal excretion through liver and bile, and entrapment into specific tissues/organs. To estimate redox information independent of clearance, the pharmacokinetic analysis of nitroxyl spin probes is therefore needed. Several groups have reported the comparison of pharmacokinetics of several nitroxyl spin probes in experimental animals (Komarov et al., 1994; Hahn et al., 1998; Takechi et al., 1997 ).
Blood and/or plasma concentration of a drug in the paramagnetic form is a most common index to estimate its in vivo pharmacokinetics. In case of rats, the time course of EPR signal intensity of the spin probes in the blood can be obtained in real time by the monitoring the circulating blood using X-band EPR (Takechi et al., 1997) . However in mice, the small blood volume and difficulty of surgical procedures make it difficult to conduct repeat sampling and/or real time measurement of the circulating blood. Therefore in most cases of pharmacokinetic studies of nitroxyl radicals in mice, EPR measurements were carried out in mouse-tail instead of blood (Komarov et al., 1994) . These results include pharmacokinetic information not only from the blood but also from tissue in the sampled region. In addition, it is not possible to determine the concentration of spin probes from in vivo EPR studies since the in vivo EPR signal intensity is not quantitative in most cases.
In our laboratory, the EPR related oxymetry, redox status estimation, and related functional imaging techniques are being investigated using mouse tumor models (Yamada et al., 2002; Matsumoto et al., 2003) . Nitroxyl radicals are used in some of these studies to non-invasively JPET #66647 6 assess tissue redox status. Additionally, nitroxyl radicals are used as in vivo radioprotectors. Therefore, the pharmacokinetic data of nitroxyl radicals in mouse blood will be useful to assess tumor redox status.
In this study, we evaluated the acute toxicity of nitroxyl spin probe after i.v. injection. We also describe a novel procedure to measure the time course of spin probe concentration in the blood of a mouse using X-band EPR spectroscopy. Using this technique, the pharmacokinetics of several nitroxyl spin probes were estimated and the pharmacokinetics results were also simulated. Suitable properties for in vivo redox probes and the radiation protection agents are discussed.
Measurement of Time Course of the Spin Probe Concentrations in Blood. Each mouse was anesthetized by isoflurane (1.5% in medical air, 700 mL/min). The tail vein was cannulated to inject spin probe solution. The jugular vein was cannulated by PE-10 tubing. The jugular cannulation was through the X-band EPR cavity and the end of the cannulation tube was connected to a syringe. The schematics of the experimental arrangement to monitor blood levels of the spin probes continuously using EPR spectroscopy are shown in Figure 1 . The cannulation line and cylinder were filled with heparinized saline. Spin probe solutions were injected via the cannula in the tail vein. Two different doses were tested for time course study of each probe except for TEMPO. The dose of TEMPO was 0.25 µmol/g b.w. based on the maximum tolerated dose (MTD). Similarly, the higher dose was decided as 0.50 µmol/g b.w. for amino-TEMPO and CAT-1, 1.00 µmol/g b.w. for TEMPONE, and 1.50 µmol/g b.w. for other probes. The lower dose was a half of higher dose. Immediately after the injection of the spin probe, blood was pumped up to the X-band EPR cavity (Varian E line, Palo Alto, CA) from the jugular vein cannulation and the EPR signal was measured. The blood was pushed back into the jugular vein after the measurement. The X-band EPR measurements were repeated over 20 min (30 min for carbamoyl-PROXYL, carboxy-PROXYL, and CAT-1) after injection of a spin probe solution.
After each measurement, 10 ~ 30 µL of heparinized saline was additionally flushed. The EPR conditions were as follows; microwave frequency was 9.4 GHz, microwave power was 10 mW, magnetic field modulation frequency was 100 kHz, magnetic field modulation amplitude was 1.0 Gauss, time constant was 0.064 sec. The spin probe solutions were diluted by PBS at several concentrations and measured with same system to obtain the standard curves. subjective. To eliminate such empirical factors, we processed the data as follows. 1) Experimental end point was decided based on 0.05%, 0.5%, and 1.2% of predicted initial blood concentration C 0 for TEMPO derivatives, carbamoyl-PROXYL, and carboxy-PROXYL. The prediction of initial blood concentration was calculated by the dose and the initial distribution volume. A blood volume of 1.95 mL for a 25 g mouse (Satoh, 1986) was used. The plasma volume was 1.07 mL for a 25 g mouse (55% of blood volume) (Rygaard and Povlsen, 1974; Kutscher and Schmalbach, 1975) . The initial distribution volume was, in this time, the double of plasma volume. 2) The slow phase was estimated by the concentration region between the final concentration (at end point) and 5-fold of the final concentration and slow component k 
Data Analysis of the
T t : Concentration of total probe (nitroxyl radical + hydroxylamine) in blood (µM) The values used for the simulation was shown in Table 1 . For initial 15 sec (0.25 min), T t was assumed to increase linearly by injection, i.e. equation (1) and (3) 
Results
Acute Toxicity by Intravenous Injection. The results are shown in Table 2 . To reduce the number of mice that would be required to determine precise MTD values, MTD values were approximated based on extrapolations between lethal and non-lethal doses. The MTD of TEMPOL should be between 2.00 and 1.50 µmol/g b.w. which is in agreement with the previous report employing i.p. injection (MTD = 275 mg/kg b.w. = 1.6 µmol/g b.w.) (Hahn et al., 1998) .
The MTD of TEMPO was below 0.25 µmol/g b.w., which was approximately 1/6 that of TEMPOL. The MTD of TEMPONE should be between 1.00 and 1.50 µmol/g b.w. which is lower than TEMPOL. A previous report (Hahn et al., 1998 ) also determined the MTD of TEMPONE by i.p. injection to be 225 mg/kg b.w. = 1.32 µmol/g b.w., which was in the same range in the present study. The MTD of amino-TEMPO should be between 0.50 and 0.75 µmol/g b.w., which is lower than TEMPOL and TEMPONE. However, a previous report (Hahn et al., 1998) mM. Though data points could not be obtained for sufficient time periods because of high background to reliably characterize it, the decay curve of TEMPO (Fig. 2C ) appeared to be biphasic as shown by simulation (Fig. 3C ). In addition, TEMPO showed relatively low initial blood concentrations than the expected value from dose administered. CAT-1, which is an extracellular probe showed a tri-phasic behavior, consisting of a short first phase, followed by slow second phase, and then a final linear decrease.
A similar tri-phasic decay, as observed for CAT-1, was shown for another membrane The decay constants of various spin probes were calculated from those plots based on a 2-compartment model analysis except for TEMPO and CAT-1 as shown in Table 3 . No marked differences were obtained between the high dose and the low dose except for TEMPOL and carboxy-TEMPO. In this experiment, the k β values followed the order: TEMPONE > amino-TEMPO > TEMPOL > carboxy-TEMPO > carboxy-PROXYL > carbamoyl-PROXYL. This finding is in agreement with previous reports (Komarov et al., 1994; Takechi et al., 1997) , except that several results reported for the order of TEMPO and amino-TEMPO was dependent on the experimental design and/or analysis. However, the k α showed a different order. For low doses, 
Discussion
The cytotoxicity of nitroxyl spin probes were reported in the order: TEMPO > TEMPONE > amino-TEMPO > TEMPOL (Kroll et al., 1999) . TEMPONE was, however, less toxic than amino-TEMPO in mice. In a living mouse, TEMPONE may be metabolized to the less toxic TEMPOL at a relatively fast rate (Kroll and Borchert, 1999) . After injection of TEMPONE, a small portion of TEMPOL signal appeared and gradually increased. TEMPONE almost completely disappeared within 10 min, after which time, only the TEMPOL signal was observed after 10 min. When potassium ferricyanide was added to collected blood 25 min after injection of TEMPONE, recovered signal was only TEMPOL (data not shown).
Generally, doses of commonly used pharmaceuticals are administered at concentrations less than 10 nmol/g in humans. The dose of spin probes used in this experiment was between 10 -100 fold higher than this value. Saturation of excretion processes could occur at such a high dose. From the pharmacokinetic results of Oxo63, the urinary excretion rate was not so high (around 0.035 min -1 ) (submitted for publication). When the blood concentration of the probe was higher than a certain extent, urinary excretion may be saturated. The time period of the saturated excretion may be shortened with decreasing dose, below which the decay curves of all probes become biphasic. The saturation period can also be shortened by membrane permeability of the probe i.e. increasing distribution volume and fecal excretion through bile. However, total concentrations of membrane permeable probes were kept in blood and/or tissues for relatively long time periods as shown in a previous report (Hahn et al., 1998) due to entero-hepatic circulation.
The decay curve profiles can be influenced by several rate factors, such as distribution, excretion, reduction and re-oxidation rates. The distribution rate should stabilize and should This article has not been copyedited and formatted. The final version may differ from this version. decrease when the probes distribute in the body. The urinary excretion could be saturated when the probe concentration in the blood is high. The urinary excretion rate will recover when the blood concentration of total probe decreases. The fecal excretion can also be expected for membrane permeable probes. The fecal excretion is comprised of three processes, i.e. excretion into bile, re-absorption from bile, and actual excretion into feces. The distribution rate and total excretion rate may change depending on blood and/or tissue concentration of the probe.
Therefore, distribution and excretion may not exhibit first order decay kinetics, and may make the biphasic decay indistinguishable under conditions when saturation of excretion has not occurred. This process should influence the total probe kinetics. In addition to this, the different types of reduction rates should be considered, but mainly a reversible one-electron reduction and an irreversible reduction. Moreover, re-oxidation of hydroxylamine to nitroxyl radical should be considered. When the reduction rate predominates, the excretion phase can be neglected.
However, in most of cases, the oxidation phase will make the profile pseudo-biphasic, because reduction and oxidation will reach an equilibrium, after which the decay rate depends primarily on the excretion rate. When the reduction rate was slow enough and the blood concentration of the probe was high enough, the saturation of total probe excretion was though obvious on the decay curve of reduced form as a triphasic profile with or without a slight shoulder (Fig. 2H) .
Based on the factors discussed above, a simulation of the decay of nitroxyl radicals in blood was proposed as described in the methods. Although this simulation was not comprehensive, some observations related to the mechanism of in vivo nitroxyl decay can be noted. Several simulations of the decay kinetics showed that, a combination of distribution and excretion is responsible for the basic biphasic decay under non-saturated conditions of excretion. When the redox contribution to the signal loss was neglected, the slope of the fast phases was dependent This article has not been copyedited and formatted. The final version may differ from this version. mainly on the distribution volume and bile excretion rate, i.e. membrane permeability. The change in reduction and re-oxidation rates, i.e. redox status, could influence the slope of the fast phase and the time taken to transform from the fast phase to the slow phase, and then cancel each other, after which the decay curve will depend primarily on distribution and/or excretion.
Therefore, the slow phase, especially at the later time regions after the administration of the probe, depends only on excretion rate. To estimate in vivo redox information from the decay constant of nitroxyl radicals in blood circulation, probes with fast reduction rates, such as the TEMPO, are sensitive because the reduction rates could predominate in the fast phase.
Most reported studies use nitroxyl radicals as redox probes where the EPR signal decay in a particular tissue and/or organ or the part of the body is followed. Different mechanisms for in vivo nitroxyl decay rate described in a previous reports (Kocherginsky and Swartz, 1995) may due to the ambiguity of measured volume and variation of treated phase. For the particular tissue and/or organ of interest, an additional compartment, which includes uptake phase and reduction phase, should be considered. Then, the decay curve will exhibit a peak followed by a biphasic profile with relatively slower initial fast phase or linear profile lacking fast phase. The reduction rate presumably predominates in EPR measurements of whole body or particular tissue and/or organ in the absence of gradients (Komarov et al., 1994; Kamatari et al., 2002) . Therefore, redox status estimation using nitroxyls as probes will be more effective when implemented in combination with EPR imaging techniques.
One of the factors determining the suitability of nitroxyl radicals as redox probes is that the molecules should be able to go into cell. However, while estimating the decay rate as an index of redox status, any traces of saturated excretion on the decay curve may be confounding.
Optimally, the fast phase and the time period needed to shift to the slow phase should be as long as possible. For in vivo EPR imaging, the administered dose should be as high as possible. The saturation of excretion might be negligible for membrane permeable probes, even at relatively high doses used. According to this hypothesis, TEMPOL and amino-TEMPO should be better redox probes among the compounds tested. While TEMPOL and amino-TEMPO may be more sensitive for redox status, carbamoyl-PROXYL is better for EPR imaging. Although the simulation of decay of carbamoyl-PROXYL showed almost no difference between total probe concentration and radical concentration, it is expected that the reduction rate will more responsive to the decay rate in tissues and/or organs.
Re-oxidation of the hydroxylamine to the corresponding nitroxyl radical is a feasible approach for radiation protection in vivo, since radiation protection is shown only for the radical form not for the hydroxylamine in vitro (Mitchell et al., 1991; Sasaki et al., 1998) .
Administration of the hydroxylamine to living mice yields radioprotection because it is reoxidized to nitroxyl radical (Hahn et al., 2000) . Re-oxidization may occur more efficiently in normal tissues compared to the hypoxic conditions expected in the tumor. Therefore, the nitroxyl radical shows radiation protection only for normal cells. To obtain selective protection, it is important to keep constant concentration of the hydroxylamine form in blood and/or tissues rather than radical form. Therefore, administration in the hydroxylamine form should be better, because of lower toxicity (Hahn et al., 2000; Zhdanov and Komarov, 1990) . Of the probes studied in this investigation, optimal choices may be carbamoyl-PROXYL and TEMPOL.
However, treatment with radical form of carbamoyl-PROXYL may result in a higher concentration of the radical, which protects not only normal tissues but also cancer and/or tumor tissues. Therefore, TEMPOL and/or TEMPOL-H may be most suitable for in vivo radiation protection.
This article has not been copyedited and formatted. The final version may differ from this version. amino-TEMPO 1.00 Mice (2/2) died within 3 min after injection.
0.75
Mice (2/2) died within 3 min after injection.
0.50
Mice (4/4) survived until sacrificed (20 min after injection).
CAT-1 1.00 Mice (2/2) died immediately after injection. 
